Antibody-based targeting of angiogenesis

Area of Science:

• Biomedical research
• Vascular biology
• Immunology

Background:

• Angiogenesis, the formation of new blood vessels, is crucial in diseases like cancer and ocular disorders.
• Selective targeting of neovasculature presents opportunities for disease diagnosis and therapy.
• Current research focuses on identifying specific markers and developing targeted therapies.

Purpose of the Study:

• To review recent advancements in identifying angiogenesis markers.
• To discuss the use of antibodies and their derivatives for in vivo neovasculature targeting.
• To explore therapeutic strategies for angiogenesis-related diseases.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of marker identification techniques for angiogenesis.
• Evaluation of antibody-based strategies for in vivo targeting.

Main Results:

• Several novel markers for angiogenesis have been identified.
• Antibodies and their derivatives show promise for targeting tumoral and nontumoral neovasculature.
• In vivo targeting strategies are advancing for various angiogenesis-related conditions.

Conclusions:

• Targeting neovasculature is a promising approach for treating angiogenesis-related diseases.
• Continued research in marker identification and antibody development is essential.
• This field holds potential for improved diagnosis and therapy in oncology and ophthalmology.